During the past decade, Kremlin Bicetre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kremlin Bicetre" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Kremlin Bicetre" in a lesser frequency.

Most popular intervention types in "Kremlin Bicetre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (1 trials), "Lenalidomide and low-dose dexamethasone" (1 trials), "Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles" (1 trials) and "Melphalan, Prednisone and Thalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kremlin Bicetre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kremlin Bicetre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kremlin Bicetre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kremlin Bicetre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".